444 filings
8-K
COSM
Cosmos Health Inc
19 Apr 24
Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-K
5:00pm
NT 10-K
COSM
Cosmos Health Inc
2 Apr 24
Notice of late annual filing
4:30pm
8-K
COSM
Cosmos Health Inc
22 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:25pm
424B3
COSM
Cosmos Health Inc
7 Mar 24
Prospectus supplement
4:31pm
424B3
COSM
Cosmos Health Inc
29 Feb 24
Prospectus supplement
4:33pm
4
Siokas Grigorios
21 Feb 24
Cosmos Health / Grigorios Siokas ownership change
10:21am
424B3
COSM
Cosmos Health Inc
15 Feb 24
Prospectus supplement
4:05pm
SC 13G
Armistice Capital, LLC
14 Feb 24
Cosmos Health / ARMISTICE CAPITAL ownership change
3:33pm
EFFECT
COSM
Cosmos Health Inc
9 Feb 24
Notice of effectiveness
12:15am
CORRESP
COSM
Cosmos Health Inc
6 Feb 24
Correspondence with SEC
12:00am
UPLOAD
COSM
Cosmos Health Inc
5 Feb 24
Letter from SEC
12:00am
S-3
COSM
Cosmos Health Inc
Shelf registration
29 Jan 24
5:15pm
8-K
COSM
Cosmos Health Inc
22 Jan 24
Cosmos Health Bolsters Presence in $400Bn+ Global Generic Drugs Market with $3.5M Acquisition of 10-Drug Portfolio
4:19pm
8-K/A
COSM
Cosmos Health Inc
29 Dec 23
Entry into a Material Definitive Agreement
5:00pm
8-K
COSM
Cosmos Health Inc
29 Dec 23
Cosmos Health Set for Substantial Growth From Acquisitions Completed in 2023
6:02am
4
Anastasios Aslidis
22 Dec 23
Cosmos Health / Anastasios Aslidis ownership change
4:05pm
8-K
COSM
Cosmos Health Inc
28 Nov 23
Departure of Directors or Certain Officers
4:05pm
8-K
COSM
Cosmos Health Inc
22 Nov 23
Cosmos Health Reports Q3 2023 Results; Revenue Increased 7% YoY, Total Assets Reached Record $71.5M with Stockholders' Equity of $44.2M or $3.4/Share
9:30am
10-Q
2023 Q3
COSM
Cosmos Health Inc
Quarterly report
20 Nov 23
4:05pm
NT 10-Q
COSM
Cosmos Health Inc
14 Nov 23
Notice of late quarterly filing
4:00pm